Prot #ANG1005-CLN-03: A Phase II, Open-Label, Multi-Center Study of ANG1005 in Patients with Recurrent High-Grade Glioma

Project: Research project

Project Details

Status	Finished
Effective start/end date	12/20/13 → 7/10/19